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Despite considerable progress in medical and epidemiologic management of outbreaks of legionnaires disease (LD), little is known about the effect of such events on survivors. Two years after the first reported outbreak of LD, in Philadelphia [1] , 58% of the patients still had not recovered fully [2] . More-detailed knowledge about recovery after LD is not available.
Long-term outcome after community-acquired pneumonia (CAP) can be described in terms of mortality during the follow-up period and in terms of lung function [3] [4] [5] . An important measure of patient well-being may be health-related quality of life (HRQL) [6, 7] . This can be assessed by use of either questionnaires about symptoms or the Medical Outcomes Study Short Form 36-item health survey (SF-36). A study that used a questionnaire that assessed symptoms found that, for patients with pneumonia, recovery to a premorbid health status required 190 days, even for patients with a low severity of illness at the time of admission to the hospital [6, 7] . In addition, HRQL (as determined by SF-36) returned to prepneumonia levels within 90 days [7] . Patients who were admitted to an intensive care unit (ICU) for lung injury and survived had an impaired quality of life, compared with matched population control subjects, even after 1-2 years of follow-up [8] [9] [10] . A factor that can contribute to impairment of HRQL is posttraumatic stress disorder (PTSD), which is characterized by the development of typical symptoms after the experience of traumatic events. In ICU survivors, an association between the development of PTSD and impaired HRQL has been demonstrated [9] .
In 1999, a large outbreak of LD among attendees of a flower show occurred in The Netherlands; 11% of the affected patients died [11] . This outbreak provided us with the opportunity to describe the persistence of symptoms and HRQL in survivors of an outbreak of LD. We also evaluated predictors, including PTSD, for persistence of symptoms and for impaired HRQL.
PATIENTS AND METHODS
Study group. In March 1999, an outbreak of LD was detected in The Netherlands [11] . Local municipal health services and hospitals were requested to report every suspected case of LD. Six months after the outbreak took place, 318 patients with suspected LD had been reported. Written informed consent to collect clinical data was obtained from 202 patients or their relatives (figure 1). The study was approved by the medical ethics committee of the Academic Medical Center in Amsterdam, The Netherlands.
Patients were considered to have LD if they had visited the flower show, had experienced symptoms compatible with pneumonia, had radiologic signs of infiltration, and had laboratory evidence of Legionella infection. For patients with confirmed LD, laboratory evidence included the following: (1) isolation of Legionella pneumophila from a respiratory sputum sample, (2) detection of L. pneumophila serogroup 1 antigen in a urine sample (by use of the Binax NOW Legionella urinary antigen test; Binax), and (3) either seroconversion to positive IgG or IgM antibody titers or a 4-fold increase in antibody titers to L. pneumophila in paired acute-phase and convalescent-phase serum samples, as determined by a commercial ELISA (Serion; Institut Virion-Serion) or a microagglutination antibody assay (Regional Laboratory of Public Health, Tilburg). For patients with probable LD, laboratory evidence included findings of a single high antibody titer (11:256), a sputum sample positive for L. pneumophila by PCR, or no laboratory evidence, provided that no other microorganism was identified. Patients without radiographic confirmation of pneumonia or without symptoms of pneumonia were excluded from the study (figure 1). All patients were treated with antibiotics for 2-3 weeks.
Follow-up. The "post-LD period" was defined as the period that began after the date that antibiotic therapy was completed, which was set at 1 April 1999 for all patients. Patients with LD were asked to complete 2 sets of questionnaires. The first set was sent to eligible patients by mail 7 months after the outbreak. Patients were asked to compare the symptoms they experienced 2 and 6 months after LD with their premorbid symptoms. The second set of questionnaires, including the symptom questionnaire, the SF-36, and the PTSD list, were sent to the patients by mail or were completed during a hospital visit related to participation in a study for the evaluation of residual pulmonary abnormalities; this set of questionnaires was completed 13-20 months after LD (mean, 17 months).
Definitions. Data on the following variables were collected from the medical hospital chart or from the general physician: (1) the patient's demographic characteristics; (2) presence of underlying conditions, such as smoking, chronic obstructive pulmonary disease (COPD), and cardiovascular disease (CVD; defined as any cardiovascular condition, including hypertension, that required medication and that was present at the time of the visit to the flower show); (3) findings of physical examination, routine laboratory investigations, and chest radiography performed at admission to the hospital and reviewed by the attending hospital radiologist; and (4) admission to the ICU and receipt of mechanical ventilation.
LD was classified as "severe" if у2 of the following minor criteria for severity of pneumonia [12] were present at admission: (1) Questionnaires. The items on the symptom questionnaire were selected by a panel of investigators on the basis of previous studies of LD and CAP [2, 7] . The questionnaire included items on the most prevalent respiratory symptoms (cough and dyspnea), fatigue, neurologic symptoms (headache, memory loss, and concentration problems) and neuromuscular symptoms (muscle/joint pain, muscle weakness, and tingling in the fingers, arms, or feet). Symptoms were scored as "present" or "absent" before LD and at 2, 6, and 17 months after LD.
The SF-36 comprises 36 items that address the following 8 dimensions believed to reflect the respondent's quality of life: ability to perform usual and vigorous activities (physical function), ability to participate in social and occupational activities (social function, physical role function, and emotional role function), moods (mental health dimension), amount of energy and pain (vitality and pain dimensions), and current health (general health perception) [13] . Each dimension is scored from 0 to 100, with higher scores indicating better quality of life. Patients' SF-36 scores were compared with published age-and sex-matched Dutch reference population norms [14] .
Presence of PTSD was measured by a questionnaire with a self-rating scale. Each item on the questionnaire corresponded to 1 of the 17 diagnostic criteria for PTSD given in the Di-
agnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).
The questionnaire has been validated with use of a sample of 136 survivors of a plane crash: Cronbach's a was .96, indicating excellent internal consistency, and sensitivity and specificity were 86% and 80%, respectively, compared with a structured interview (the gold standard) [15] . Items on the questionnaire are clustered into the following categories: reexperience symptoms (5 items), avoidance symptoms (7 items), and hyperarousal symptoms (5 items). Severity is rated on a 3-point scale, in which a score of 0 indicates "not at all"; a score of 1 indicates "slightly," "once," or "!4 times"; and a score of 2 indicates "very much," "almost constantly," or "у4 times." A symptom is rated as "present" if the score for an item is у1 on the severity scale or, for some items, у2. PTSD is diagnosed if at least 1 reexperience symptom, 3 avoidance symptoms, and 2 hyperarousal symptoms are present. The patients in our study were not aware that the questionnaire was used to establish the possible diagnosis of PTSD.
Statistical analysis. Continuous variables were compared by means of Student's t test for groups; categorical variables were assessed by the x 2 test or Fisher's exact test. Symptom resolution 2-17 months after LD was determined by means of McNemar's x 2 test. A 2-tailed P value of ! .05 was considered statistically significant.
The 8 dimensions of the SF-36 score were converted to standard scores on the basis of the scores of an age-and sexmatched representative reference sample of the Dutch population. Standard scores were calculated by dividing the difference between the patients' SF-36 score and the mean score of the matched reference population by the SDs of the reference population. A standard score thus indicates how many SDs the observed SF-36 score falls below or above the score of the reference population. Consequently, scores of the reference population are set at 0. Because it is similar to the effect size calculation, a mean standard score of 0.20 is considered to indicate a small deviation from the reference population [16] , and mean standard scores of 0.50 and 0.80 are considered to indicate moderate and large deviations from the reference population, respectively.
Mean standard scores of patients with LD were compared with those of the Dutch reference population by means of a 1-sample t test (i.e., by testing whether mean standard scores from patients with LD were significantly different from zero). HRQL scores for patients with and for patients without persisting symptoms were compared by means of 1-way analysis of variance (ANOVA).
RESULTS

Patient characteristics.
For the follow-up study, 142 eligible patients were asked to participate, and 122 patients agreed to do so (figure 1). Of these 122 patients, 86 participated in the study that evaluated residual pulmonary abnormalities and also completed the questionnaires during the same hospital visit. There were no significant differences between the characteristics of patients who returned the second set of questionnaires by mail and the characteristics of those who completed these questionnaires during the hospital visit; therefore, data for both groups were combined in the analysis.
The median age of the patients was 66 years (range, 25-87 years); 60% were men, and most patients were hospitalized (table 1) . Thirty-three patients (27%) fulfilled the criteria for presence of severe LD, 23 patients (19%) survived their stay in the ICU, and 14 patients (11%) needed to receive mechanical ventilation. Premorbid conditions, such COPD, diabetes mellitus, cancer, or immunosuppression due to disease or medication, were infrequently reported (in !10% of patients). CVD was reported in 33% of the patients, and 47% of the patients were active smokers (у1 cigarette per day) at the time of hospital admission.
Questionnaires. The most frequently reported new symptoms 2 months after LD were fatigue (reported by 81% of patients); neurologic symptoms, such as concentration problems and memory loss (75% of patients); and neuromuscular symptoms, such as muscle/joint pain or muscle weakness (79% of patients) (table 2). Coughing (48%) and dyspnea on exertion (38%) were the most commonly reported new respiratory symptoms. The prevalence of each symptom decreased at each subsequent follow-up visit, but a substantial number of symp- toms were still reported 17 months after LD. Only the decline in neurologic and neuromuscular symptoms between 2 and 17 months after LD reached statistical significance (table 2) . Seventeen months after LD, patients had lower scores for 7 of the 8 dimensions of the SF-36 than did a Dutch age-and sex-matched reference population (figure 2). For these 7 dimensions, the deviation of the HRQL score from that of the reference population was statistically significant ( ). The P ! .01 most severely reduced dimensions were physical role function (standard score, Ϫ0.68), general health (standard score, Ϫ0.64), and vitality (standard score, Ϫ0.55). PTSD was present in 18 patients (15%). Only 1 of these patients had actually been treated for PTSD by a psychiatrist at the time of examination. In summary, 17 months after the outbreak of LD, the majority of patients experienced persistent symptoms and impaired HRQL, and 15% experienced PTSD.
Predisposing conditions for impaired well-being and PTSD.
Because premorbid conditions and traumatizing events during hospitalization have been associated with impaired HRQL and with PTSD [9, 17, 18] , we determined whether persistence of self-reported symptoms, impaired HRQL, and presence of PTSD was associated with premorbid conditions (i.e., age 166 years, sex, COPD, CVD, and smoking) or determinants of severity of disease (i.e., severe LD, ICU admission, use of mechanical ventilation, and relatively long hospital stay). Men reported significantly less dyspnea on exertion than did women (RR, 0.5; 95% CI, 0.3-0.9), and patients who were active smokers reported more muscular signs than did nonsmokers (RR, 1.6; 95% CI, 1.2-2.1). Other premorbid conditions or disease determinants were not associated with the presence of any of the symptoms 17 months after LD. Likewise, no significant association was found between severity of pneumonia or ICU admission and HRQL dimensions. However, patients with a history of CVD (median age, 73 years; range, 53-87 years) had significantly more impairment in physical function, physical role function, general health, and vitality ( ; Student's t test) than did patients without a history P ! .05 of CVD (median age, 64 years; range, 25-78 years). NOTE. The questionnaire for assessment of PTSD was completed by 120 patients. Eighteen patients (15%) fulfilled the criteria for PTSD.
a That is, being above the 25th percentile for age.
b ; x 2 test. P ! .05 c Adequate antibiotic therapy initiated 124 h after admission to the hospital.
Younger patients (those aged !56 years; i.e., those below the 25th percentile for age) were more likely to develop PTSD than were older patients (  , table 3 ). Sex, presence of un-P p .039 derlying conditions, and fulfillment of the criteria for severe LD were not associated with the development of PTSD.
Relationships among self-reported symptoms, HRQL, and PTSD. HRQL was significantly lower for patients who reported fatigue, coughing or shortness of breath on exertion, neurologic symptoms, or neuromuscular symptoms, compared with the patients who did not report these symptoms (in all cases , ANOVA). In particular, large deviations P ! .05 from population norms for physical function, physical role function, and general health were found for patients who reported symptoms. As expected, HRQL was significantly lower among patients with PTSD than among patients without PTSD for all 8 dimensions assessed by the SF-36 (in all cases, , by t test). P ! .05
DISCUSSION
We described the symptoms and assessments of well-being for a large and well-defined group of 122 patients who survived LD. The most prevalent symptoms persisting 17 months after LD were fatigue (in 75% of patients), neurologic symptoms (in 66%), and neuromuscular symptoms (in 63%). Respiratory symptoms, such as coughing (in 39% of patients) and shortness of breath (in 28%), were also commonly reported. In contrast to symptoms after CAP, there was little improvement of selfreported symptoms between 2 and 17 months after LD. HRQL was significantly impaired for 7 of 8 dimensions assessed by the SF-36, and PTSD could be demonstrated in 15% of the patients. Thus, LD can affect health status in a large proportion of patients for at least 1.5 years after the completion of antibiotic treatment for the disease.
Persistence of symptoms, such as fatigue and dyspnea, was also described in 18 of 31 people 2 years after the LD outbreak in Philadelphia [2] . Of the age-matched legionnaires who attended the convention but did not meet the clinical epidemiologic diagnostic criteria [1] , only 6% noted fatigue, and 3% reported dyspnea on exertion. In addition, of patients who had low-risk CAP [19] , 51% reported fatigue and 28% reported dyspnea up to 3 months after the completion of antibiotic treatment [6, 7] . The SF-36 indicated that, in these patients, HRQL returned to prepneumonia levels 3 months after completion of antibiotic treatment [6] . However, the period of persistence of symptoms may be longer for patients with high-risk CAP, which suggests that persistence of symptoms and impaired quality of life in the patients who had had LD might not be unique to L. pneumophila pneumonia, but might be associated with severe pneumonia in general.
We could not demonstrate a significant association between persistence of symptoms or impaired HRQL and either premorbid conditions, severity of pneumonia, delay in antibiotic treatment, or length of hospital stay. In contrast, Marrie et al. [17] reported an association between persistence of symptoms and age, COPD, and treatment with levofloxacin. This difference might be explained by the duration of follow-up, which was 6 weeks in the study of Marrie et al. [17] and 17 months in the present study.
Impaired HRQL and persistence of symptoms have also been demonstrated 1-2 years after ICU admission, especially in patients with acute lung injury or acute respiratory distress syndrome [8, 10, 20, 21] . We could not demonstrate a significant increase in self-reported symptoms or impaired HRQL in patients who had had LD and who had been admitted to the ICU or had received mechanical ventilation, compared with patients who had not. No association was found between self-reported symptoms or impaired HRQL (except for the dimension of physical role function) and the presence of pulmonary abnormalities 17 months after LD (R.E.J., unpublished data). This suggests that the high percentage of patients who required admission to the ICU and who had pulmonary damage secondary to L. pneumophila pneumonia does not explain the incidence of persistence of symptoms in our study population.
Another factor that can contribute to persistence of symptoms and impairment of well-being is PTSD. Patients who are admitted to the ICU with lung injury and survive often report nonpulmonary symptoms, such as difficulty concentrating and memory loss [8] . Patients admitted to the ICU are exposed to stress by systemic infection [22] , and staying in the ICU environment can be a stressful event. According to the definition of PTSD in DSM-IV, such a person has been exposed to a traumatic event and meets both of the following 2 criteria: (1) the person experienced, witnessed, or was confronted with an event that involved actual or threatened death or serious injury, or a threat to the physical integrity of self or others, and (2) the person's response to the event involved intense fear, helplessness, or horror. Life-threatening disease is an example of such a stressful event [23] . Major impairments in the mental health dimensions of HRQL have been associated with the development of PTSD in such patients [9, 18] . In the patients we studied, we also found an association between admission to the ICU and development of PTSD, although it was not statistically significant, probably because of the small number of patients. HRQL scores were, indeed, lower for patients who met the criteria for having PTSD.
Unexplained self-reported symptoms were found at similar frequencies among a group of people who survived a plane crash into a neighborhood in Amsterdam [24] and among soldiers who served in the Gulf War [25] . The percentage of symptomatic soldiers in the Gulf War who had PTSD was 5%-15% [26] . The percentage of patients with PTSD in our study (15%) is in agreement with estimations that, in the aftermath of a disaster, 20%-30% of victims develop PTSD [27] . Also, patients who do not meet the criteria that define PTSD (according to DSM-IV) may experience symptoms such as reexperience, avoidance, or hyperarousal. Therefore, we cannot exclude the possibility that having experienced a life-threatening illness and being part of an outbreak that was widely and frequently covered in the media plays a role in the development of the observed sequelae. Also, the intense and exaggerated fear of situations in daily life that have been linked to LD, such as contact with water in showers and sprinkler installations, which can lead to renewed infection with L. pneumophila, may play an additional role in the development of chronic stress and the subsequent persistence of symptoms.
This study does not answer the question of whether L. pneumophila itself, severe pneumonia in general, or the outbreak of LD itself is responsible for the impairment of well-being. Moreconclusive answers regarding the specific cause of impairment would require the use of both matched control subjects with severe pneumonia and matched control subjects who contracted LD in the absence of an outbreak. Because of the relatively low incidence of LD and the rarity of well-documented LD outbreaks, a study designed to answer these questions would not be feasible. However, our results indicate that health care providers should be aware of the possibility of persisting symptoms, impaired HRQL, and high frequency of (partial) PTSD, especially in an outbreak situation, because patients will seek help for their complaints. Awareness of this problem will make it possible to improve health care for such patients.
